A detailed history of Beryl Capital Management LLC transactions in Fusion Pharmaceuticals Inc. stock. As of the latest transaction made, Beryl Capital Management LLC holds 16,191 shares of FUSN stock, worth $0. This represents 0.44% of its overall portfolio holdings.

Number of Shares
16,191
Holding current value
$0
% of portfolio
0.44%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$7.9 - $21.32 $127,908 - $345,192
16,191 New
16,191 $345,000

Others Institutions Holding FUSN

About Fusion Pharmaceuticals Inc.


  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Beryl Capital Management LLC Portfolio

Follow Beryl Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beryl Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beryl Capital Management LLC with notifications on news.